Envision Healthcare Corporation (NYSE:EVHC) issued an update on its FY17 earnings guidance on Monday morning. The company provided earnings per share guidance of $3.35-3.45 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.45. The company issued revenue guidance of $7.75-8.0 billion, compared to the consensus revenue estimate of $7.96 billion.Envision Healthcare Corporation also updated its Q3 guidance to $0.87-0.83 EPS.
Shares of Envision Healthcare Corporation (NYSE EVHC) traded up 0.66% during midday trading on Friday, reaching $50.21. The company had a trading volume of 1,433,281 shares. The firm’s 50 day moving average price is $57.66 and its 200-day moving average price is $60.47. Envision Healthcare Corporation has a 1-year low of $49.56 and a 1-year high of $74.75. The stock’s market capitalization is $5.88 billion.
Envision Healthcare Corporation (NYSE:EVHC) last released its quarterly earnings results on Monday, August 7th. The company reported $0.79 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.75 by $0.04. Envision Healthcare Corporation had a positive return on equity of 5.35% and a negative net margin of 7.35%. The firm had revenue of $1.95 billion for the quarter, compared to analyst estimates of $1.96 billion. During the same quarter last year, the company posted $0.34 earnings per share. The business’s revenue was up 156.7% on a year-over-year basis. Equities research analysts expect that Envision Healthcare Corporation will post $1.40 EPS for the current fiscal year.
EVHC has been the topic of a number of research reports. Royal Bank Of Canada reissued a buy rating and set a $72.00 price target on shares of Envision Healthcare Corporation in a report on Monday, June 5th. Jefferies Group LLC reissued a buy rating and set a $71.00 price target (down previously from $75.00) on shares of Envision Healthcare Corporation in a report on Wednesday, May 3rd. Cantor Fitzgerald reissued a buy rating and set a $80.00 price target on shares of Envision Healthcare Corporation in a report on Tuesday, July 4th. Zacks Investment Research raised Envision Healthcare Corporation from a strong sell rating to a buy rating and set a $70.00 price target on the stock in a report on Tuesday, July 4th. Finally, BidaskClub raised Envision Healthcare Corporation from a sell rating to a hold rating in a report on Saturday, June 17th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. Envision Healthcare Corporation currently has a consensus rating of Buy and a consensus target price of $71.56.
In related news, insider Robert Jon Coward sold 1,500 shares of Envision Healthcare Corporation stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $62.69, for a total transaction of $94,035.00. Following the completion of the transaction, the insider now directly owns 97,863 shares in the company, valued at approximately $6,135,031.47. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 3.10% of the company’s stock.
WARNING: “Envision Healthcare Corporation (NYSE:EVHC) Releases FY17 Earnings Guidance” was posted by BNB Daily and is the property of of BNB Daily. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright laws. The correct version of this article can be read at https://www.baseball-news-blog.com/2017/08/19/envision-healthcare-corporation-nyseevhc-updates-fy17-earnings-guidance-updated.html.
About Envision Healthcare Corporation
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.